{"DataElement":{"publicId":"3173724","version":"1","preferredName":"Salvage Therapy Identifier Type","preferredDefinition":"a subdivision to identify a specific salvage therapy.","longName":"2014118v1.0:3173723v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2014118","version":"1","preferredName":"Salvage Therapy Identifier","preferredDefinition":"the means to uniquely identify a specific salvage therapy.","longName":"SALVAGETX_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177011","version":"1","preferredName":"Salvage Therapy","preferredDefinition":"Treatment that is given after the cancer has not responded to other treatments.","longName":"Salvage Therapy","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Salvage Therapy","conceptCode":"C15359","definition":"Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory support. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AD8-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222848","version":"1","preferredName":"Identifier","preferredDefinition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62113C1-8528-4E73-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53A2366-F07E-31A7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3173723","version":"1","preferredName":"Salvage Therapy Type","preferredDefinition":"a subdivision of salvage therapy.","longName":"3173723v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Surgery","valueDescription":"Surgery","ValueMeaning":{"publicId":"2560125","version":"1","preferredName":"Surgery","longName":"2560125","preferredDefinition":"A specialty in which manual or operative procedures are used in the treatment of disease, injuries, or deformities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgery","conceptCode":"C17173","definition":"The branch of medical science that treats disease or injury by operative procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EE67EB-7339-3463-E040-BB89AD4305CD","beginDate":"2010-12-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"Radiation Therapy","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"2717922","version":"1","preferredName":"Radiation Therapy","longName":"2717922","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42BFA254-C33F-032A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EE67EB-7343-3463-E040-BB89AD4305CD","beginDate":"2010-12-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"Immunotherapy","valueDescription":"Immunotherapy","ValueMeaning":{"publicId":"2558928","version":"1","preferredName":"Immunotherapy","longName":"2558928","preferredDefinition":"(IM-yoo-no-THER-a-pee) Treatment to stimulate or restore the ability of the immune system to fight infections and other diseases. Also used to lessen side effects that may be caused by some cancer treatments.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B33D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2009-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EE67EB-734D-3463-E040-BB89AD4305CD","beginDate":"2010-12-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"Chemotherapy","valueDescription":"Chemotherapy","ValueMeaning":{"publicId":"2570169","version":"1","preferredName":"Chemotherapy","longName":"2570169","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF26-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2022-11-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EE67EB-7357-3463-E040-BB89AD4305CD","beginDate":"2010-12-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D599EDE-241F-B7EA-E040-BB89AD43227E","beginDate":"2011-02-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-02-28","modifiedBy":"ONEDATA","dateModified":"2011-02-28","deletedIndicator":"No"},{"value":"Radiofrequency Ablation","valueDescription":"Radiofrequency Ablation","ValueMeaning":{"publicId":"3029158","version":"1","preferredName":"Radiofrequency Ablation","longName":"3029158","preferredDefinition":"A therapeutic procedure to eradicate or reduce small tumors using radiowaves to generate heat. The procedure is performed by the insertion of a thin needle through the skin and into a tumor, which is guided by computed tomography (CT) or ultrasound. Electrical energy delivered through this needle (electrode) heats and destroys the tumor. This therapeutic option is widely utilized by patients that have inoperable cancers, or are unsuitable chemotherapy candidates.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiofrequency Ablation","conceptCode":"C15666","definition":"A therapeutic procedure to kill tissue using radiowaves to generate heat. The procedure is performed by the insertion of an electrode into a target tissue. Electrical energy delivered to the electrode heats and destroys the tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"828E0AA4-2120-D102-E040-BB89AD4302B8","latestVersionIndicator":"Yes","beginDate":"2010-03-24","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-24","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D599EDE-2429-B7EA-E040-BB89AD43227E","beginDate":"2011-02-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-02-28","modifiedBy":"ONEDATA","dateModified":"2011-02-28","deletedIndicator":"No"},{"value":"SBRT","valueDescription":"Stereotactic Body Radiation Therapy","ValueMeaning":{"publicId":"3193538","version":"1","preferredName":"Stereotactic Body Radiation Therapy","longName":"3193538","preferredDefinition":"Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stereotactic Body Radiation Therapy","conceptCode":"C118286","definition":"Stereotactic radiation therapy in which one or several maximum dose radiation treatments are delivered targeting cancers of the body, excluding the brain or spine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D599EDE-2433-B7EA-E040-BB89AD43227E","latestVersionIndicator":"Yes","beginDate":"2011-02-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-02-28","modifiedBy":"KUMMEROA","dateModified":"2024-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D599EDE-244B-B7EA-E040-BB89AD43227E","beginDate":"2011-02-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2011-02-28","modifiedBy":"ONEDATA","dateModified":"2011-02-28","deletedIndicator":"No"},{"value":"Anti-PDL1 antibody","valueDescription":"Anti-PD-L1 antibody","ValueMeaning":{"publicId":"3304775","version":"1","preferredName":"Anti-PD-L1 antibody","longName":"3304775","preferredDefinition":"A humanized monoclonal antibody directed against human PD-L1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activities.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1E102A3-953C-BD84-E040-BB89AD432297","latestVersionIndicator":"Yes","beginDate":"2011-11-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1E102A3-9555-BD84-E040-BB89AD432297","beginDate":"2011-11-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-16","modifiedBy":"ONEDATA","dateModified":"2011-11-16","deletedIndicator":"No"},{"value":"Anti-PD1 antibody","valueDescription":"Anti-PD1 antibody","ValueMeaning":{"publicId":"3304776","version":"1","preferredName":"Anti-PD1 antibody","longName":"3304776","preferredDefinition":"A humanized monoclonal antibody directed against human PD-1 (programmed cell death 1; PDCD1), with immunomodulating and antitumor activities.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1E102A3-955F-BD84-E040-BB89AD432297","latestVersionIndicator":"Yes","beginDate":"2011-11-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1E102A3-9578-BD84-E040-BB89AD432297","beginDate":"2011-11-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-11-16","modifiedBy":"ONEDATA","dateModified":"2011-11-16","deletedIndicator":"No"},{"value":"Immunotherapy - Other","valueDescription":"Immunotherapy - Other","ValueMeaning":{"publicId":"4780580","version":"1","preferredName":"Immunotherapy - Other","longName":"4780580","preferredDefinition":"Immunotherapy - Other","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1323EF80-F98F-173F-E050-BB89AD437B30","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1323EF80-F9A8-173F-E050-BB89AD437B30","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Immunotherapy - Other anti-PD1","valueDescription":"Immunotherapy - Other anti-PD1","ValueMeaning":{"publicId":"4780581","version":"1","preferredName":"Immunotherapy - Other anti-PD1","longName":"4780581","preferredDefinition":"Immunotherapy - Other anti-PD1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1323EF80-F9B2-173F-E050-BB89AD437B30","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1323EF80-F9CB-173F-E050-BB89AD437B30","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Immunotherapy - Repeat Ipilimumab","valueDescription":"Immunotherapy - Repeat Ipilimumab","ValueMeaning":{"publicId":"4780582","version":"1","preferredName":"Immunotherapy - Repeat Ipilimumab","longName":"4780582","preferredDefinition":"Immunotherapy - Repeat Ipilimumab","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1323EF80-F9D5-173F-E050-BB89AD437B30","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1323EF80-F9EE-173F-E050-BB89AD437B30","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Molecularly targeted therapy - Other","valueDescription":"Molecularly targeted therapy - Other","ValueMeaning":{"publicId":"4780583","version":"1","preferredName":"Molecularly targeted therapy - Other","longName":"4780583","preferredDefinition":"Molecularly targeted therapy - Other","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1323EF80-F9F8-173F-E050-BB89AD437B30","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1323EF80-FA11-173F-E050-BB89AD437B30","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Molecularly targeted therapy - BRAFi +/- MEK","valueDescription":"Molecularly targeted therapy - BRAFi +/- MEK","ValueMeaning":{"publicId":"4780584","version":"1","preferredName":"Molecularly targeted therapy - BRAFi +/- MEK","longName":"4780584","preferredDefinition":"Molecularly targeted therapy - BRAFi +/- MEK","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1323EF80-FA1B-173F-E050-BB89AD437B30","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1323EF80-FA34-173F-E050-BB89AD437B30","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Cytotoxic Chemotherapy","valueDescription":"Cytotoxic Chemotherapy","ValueMeaning":{"publicId":"4780585","version":"1","preferredName":"Cytotoxic Chemotherapy","longName":"4780585","preferredDefinition":"Anticancer drugs that kill cells, especially cancer cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxic Chemotherapy","conceptCode":"C15681","definition":"A drug therapy that is used to destroy cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1323EF80-FA3E-173F-E050-BB89AD437B30","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1323EF80-FA57-173F-E050-BB89AD437B30","beginDate":"2015-04-07","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EE67EB-7323-3463-E040-BB89AD4305CD","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-12-21","modifiedBy":"ROUILLAS","dateModified":"2015-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"Type of Salvage Therapy","type":"Preferred Question Text","description":"Type of Salvage Therapy","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Type of local salvage therapy","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"97EE67EB-7361-3463-E040-BB89AD4305CD","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-12-21","modifiedBy":"ROUILLAS","dateModified":"2014-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}